- Fund name: Life Sciences Partners VI (LSP 6)
- Amount raised: $600 million
- Target size: $450 million
- Hard-cap: $600 million
- Stage of fundraising: Final close
- Final close date: March 2020
- Predecessor fund: Life Sciences Partners V (LSP 5) ($280 million)
Life Science Partners has closed its latest fund at its $600 million hard-cap. Life Sciences Partners VI (LSP 6) will follow the investment strategy of its predecessor funds investing in 15-18 predominantly European private companies developing new medications or medical technologies.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: 
